Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype.
about
The tumor microenvironment shapes hallmarks of mature B-cell malignancies.MTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma.Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures.Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway.CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo.MTI-101 (cyclized HYD1) binds a CD44 containing complex and induces necrotic cell death in multiple myelomaThe role of ubiquitin-specific protease 14 (USP14) in cell adhesion-mediated drug resistance (CAM-DR) of multiple myeloma cells.Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma.Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma.Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells.A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma.Integrin signaling in cancer cell survival and chemoresistanceAssociation of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
P2860
Q27687567-5A6AC42B-4FA7-4F31-B230-BD89CB92962AQ33758880-B8D841A0-3FA0-4A90-8D9C-5AC704C5B258Q35219539-70A94B0A-76E9-4C85-83ED-1CF2F440559CQ36503284-920ECCA3-609B-4880-9224-D67B7BC7F2E7Q37249490-594EE783-6ADA-4270-A93D-2ADE2D99BAA3Q37385307-AF05C98C-D6DD-43EF-8D22-8B15CED6455BQ38734491-9979B82C-7EA4-4270-8EF6-4A9672DD537FQ38763444-C50614B3-4B44-4317-8A44-B32CB7BEA337Q38853857-1DADEE58-001C-4F48-B94B-7DB5C7E5B06AQ38895636-C68753CA-8A10-43AC-A055-B37947C43601Q39048563-DA04C9A8-CF9C-4827-990E-F72BF22E0093Q42198719-B544551A-7852-4032-818E-DC184B2AE4A4Q42263223-5D49DA06-DE16-456E-A96E-9096A4E40E28
P2860
Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Acquisition of resistance towa ...... compromised CAM-DR phenotype.
@ast
Acquisition of resistance towa ...... compromised CAM-DR phenotype.
@en
type
label
Acquisition of resistance towa ...... compromised CAM-DR phenotype.
@ast
Acquisition of resistance towa ...... compromised CAM-DR phenotype.
@en
prefLabel
Acquisition of resistance towa ...... compromised CAM-DR phenotype.
@ast
Acquisition of resistance towa ...... compromised CAM-DR phenotype.
@en
P2093
P2860
P1476
Acquisition of resistance towa ...... compromised CAM-DR phenotype.
@en
P2093
Anthony W Gebhard
Lori A Hazlehurst
Mark L McLaughlin
Michael F Emmons
Rachid Baz
Rajesh R Nair
P2860
P304
P356
10.1158/1535-7163.MCT-11-0149
P50
P577
2011-10-06T00:00:00Z